Prelude Therapeutics Inc Quarterly Marketable Securities, Current in USD from Q3 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Prelude Therapeutics Inc quarterly Marketable Securities, Current history and growth rate from Q3 2021 to Q2 2024.
  • Prelude Therapeutics Inc Marketable Securities, Current for the quarter ending June 30, 2024 was $152M, a 33.5% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $152M -$76.5M -33.5% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $177M +$23.2M +15% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $208M +$36.5M +21.3% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $215M +$42.6M +24.8% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $229M +$32.9M +16.8% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $154M -$60.5M -28.2% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $171M -$88.3M -34% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $172M -$87.4M -33.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $196M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $215M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $259M Dec 31, 2021 10-K 2023-03-15
Q3 2021 $259M Sep 30, 2021 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.